$SNOA
Sonoma Pharmaceuticals, Inc.

2021 Q4 Form 10-Q Financial Statement

#000168316822000877 Filed on February 11, 2022

View on sec.gov

Income Statement

Concept 2021 Q4
Revenue $2.902M
YoY Change -41.26%
Cost Of Revenue $1.685M
YoY Change -50.87%
Gross Profit $1.217M
YoY Change -19.4%
Gross Profit Margin 41.94%
Selling, General & Admin $2.135M
YoY Change 1.67%
% of Gross Profit 175.43%
Research & Development $26.00K
YoY Change -13.33%
% of Gross Profit 2.14%
Depreciation & Amortization $37.00K
YoY Change -53.75%
% of Gross Profit 3.04%
Operating Expenses $2.161M
YoY Change 1.46%
Operating Profit -$944.0K
YoY Change 52.26%
Interest Expense $3.000K
YoY Change
% of Operating Profit
Other Income/Expense, Net $11.00K
YoY Change -102.24%
Pretax Income -$944.0K
YoY Change 49.84%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$944.0K
YoY Change 45.23%
Net Earnings / Revenue -32.53%
Basic Earnings Per Share -$0.31
Diluted Earnings Per Share -$306.5K
COMMON SHARES
Basic Shares Outstanding 3.080K shares
Diluted Shares Outstanding 3.080K shares

Balance Sheet

Concept 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.529M
YoY Change 53.95%
Cash & Equivalents $8.529M
Short-Term Investments
Other Short-Term Assets $3.437M
YoY Change 3.84%
Inventory $2.879M
Prepaid Expenses
Receivables $2.854M
Other Receivables $0.00
Total Short-Term Assets $17.70M
YoY Change 9.19%
LONG-TERM ASSETS
Property, Plant & Equipment $922.0K
YoY Change -14.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $726.0K
YoY Change -22.77%
Total Long-Term Assets $1.648M
YoY Change -18.42%
TOTAL ASSETS
Total Short-Term Assets $17.70M
Total Long-Term Assets $1.648M
Total Assets $19.35M
YoY Change 6.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.583M
YoY Change -34.86%
Accrued Expenses $1.553M
YoY Change 24.24%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $587.0K
YoY Change
Total Short-Term Liabilities $3.875M
YoY Change -0.13%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities $4.303M
YoY Change 497.64%
Total Long-Term Liabilities $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.875M
Total Long-Term Liabilities $0.00
Total Liabilities $8.178M
YoY Change 38.14%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.17M
YoY Change
Total Liabilities & Shareholders Equity $19.35M
YoY Change 6.13%

Cashflow Statement

Concept 2021 Q4
OPERATING ACTIVITIES
Net Income -$944.0K
YoY Change 45.23%
Depreciation, Depletion And Amortization $37.00K
YoY Change -53.75%
Cash From Operating Activities -$326.0K
YoY Change -143.47%
INVESTING ACTIVITIES
Capital Expenditures -$1.000K
YoY Change -98.57%
Acquisitions
YoY Change
Other Investing Activities $1.000K
YoY Change
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 463.0K
YoY Change 92.92%
NET CHANGE
Cash From Operating Activities -326.0K
Cash From Investing Activities 0.000
Cash From Financing Activities 463.0K
Net Change In Cash 137.0K
YoY Change -84.78%
FREE CASH FLOW
Cash From Operating Activities -$326.0K
Capital Expenditures -$1.000K
Free Cash Flow -$325.0K
YoY Change -139.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
USD
CY2021Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
USD
SNOA Forgiveness Of Ppp Loan
ForgivenessOfPppLoan
USD
SNOA Increase Decrease In Withholding Tax Payable
IncreaseDecreaseInWithholdingTaxPayable
USD
CY2020Q2 SNOA Conversion Of Series C Convertible Preferred Stock Into Common Stock
ConversionOfSeriesCConvertiblePreferredStockIntoCommonStock
USD

Files In Submission

Name View Source Status
0001683168-22-000877-index-headers.html Edgar Link pending
0001683168-22-000877-index.html Edgar Link pending
0001683168-22-000877.txt Edgar Link pending
0001683168-22-000877-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snoa-20211231.xsd Edgar Link pending
snoa-20211231_cal.xml Edgar Link unprocessable
snoa-20211231_def.xml Edgar Link unprocessable
snoa-20211231_lab.xml Edgar Link unprocessable
snoa-20211231_pre.xml Edgar Link unprocessable
sonoma_ex3101.htm Edgar Link pending
sonoma_ex3102.htm Edgar Link pending
sonoma_ex3201.htm Edgar Link pending
sonoma_i10q-123121.htm Edgar Link pending
sonoma_i10q-123121_htm.xml Edgar Link completed